Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 6
1998 4
1999 1
2000 7
2001 6
2002 3
2003 5
2004 5
2005 12
2006 4
2007 2
2008 2
2009 4
2010 3
2011 6
2012 6
2013 4
2014 8
2015 3
2016 3
2017 3
2018 2
2019 6
2020 5
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Results by year
Filters applied: . Clear all
Page 1
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation.
Zhang H, Freitas D, Kim HS, Fabijanic K, Li Z, Chen H, Mark MT, Molina H, Martin AB, Bojmar L, Fang J, Rampersaud S, Hoshino A, Matei I, Kenific CM, Nakajima M, Mutvei AP, Sansone P, Buehring W, Wang H, Jimenez JP, Cohen-Gould L, Paknejad N, Brendel M, Manova-Todorova K, Magalhães A, Ferreira JA, Osório H, Silva AM, Massey A, Cubillos-Ruiz JR, Galletti G, Giannakakou P, Cuervo AM, Blenis J, Schwartz R, Brady MS, Peinado H, Bromberg J, Matsui H, Reis CA, Lyden D. Zhang H, et al. Among authors: giannakakou p. Nat Cell Biol. 2018 Mar;20(3):332-343. doi: 10.1038/s41556-018-0040-4. Epub 2018 Feb 19. Nat Cell Biol. 2018. PMID: 29459780 Free PMC article.
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer.
Armstrong AJ, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Anand M, Berry WR, Zhang T, Harrison MR, Lu C, Chen Y, Galletti G, Schonhoft JD, Scher HI, Wenstrup R, Tagawa ST, Antonarakis ES, George DJ, Halabi S. Armstrong AJ, et al. Among authors: giannakakou p. JCO Precis Oncol. 2020 Oct 28;4:PO.20.00200. doi: 10.1200/PO.20.00200. eCollection 2020. JCO Precis Oncol. 2020. PMID: 33154984 Free PMC article.
Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.
Armstrong AJ, Halabi S, Luo J, Nanus DM, Giannakakou P, Szmulewitz RZ, Danila DC, Healy P, Anand M, Rothwell CJ, Rasmussen J, Thornburg B, Berry WR, Wilder RS, Lu C, Chen Y, Silberstein JL, Kemeny G, Galletti G, Somarelli JA, Gupta S, Gregory SG, Scher HI, Dittamore R, Tagawa ST, Antonarakis ES, George DJ. Armstrong AJ, et al. Among authors: giannakakou p. J Clin Oncol. 2019 May 1;37(13):1120-1129. doi: 10.1200/JCO.18.01731. Epub 2019 Mar 13. J Clin Oncol. 2019. PMID: 30865549 Free PMC article. Clinical Trial.
Reply.
Gussio R, Fojo T, Giannakakou P. Gussio R, et al. Among authors: giannakakou p. Trends Pharmacol Sci. 2000 Sep;21(9):323-4. doi: 10.1016/s0165-6147(00)01522-4. Trends Pharmacol Sci. 2000. PMID: 10973075 No abstract available.
Microtubule Engagement with Taxane Is Altered in Taxane-Resistant Gastric Cancer.
Galletti G, Zhang C, Gjyrezi A, Cleveland K, Zhang J, Powell S, Thakkar PV, Betel D, Shah MA, Giannakakou P. Galletti G, et al. Among authors: giannakakou p. Clin Cancer Res. 2020 Jul 15;26(14):3771-3783. doi: 10.1158/1078-0432.CCR-19-3018. Epub 2020 Apr 22. Clin Cancer Res. 2020. PMID: 32321717 Free PMC article.
Clinical Significance of AR-V567es in Prostate Cancer-Response.
Tagawa ST, Antonarakis ES, Gjyrezi A, Galletti G, Giannakakou P. Tagawa ST, et al. Among authors: giannakakou p. Clin Cancer Res. 2019 Oct 1;25(19):6010-6011. doi: 10.1158/1078-0432.CCR-19-1820. Clin Cancer Res. 2019. PMID: 31575715 Free article. No abstract available.
Taxane resistance in prostate cancer is mediated by decreased drug-target engagement.
Gjyrezi A, Xie F, Voznesensky O, Khanna P, Calagua C, Bai Y, Kung J, Wu J, Corey E, Montgomery B, Mace S, Gianolio DA, Bubley GJ, Balk SP, Giannakakou P, Bhatt RS. Gjyrezi A, et al. Among authors: giannakakou p. J Clin Invest. 2020 Jun 1;130(6):3287-3298. doi: 10.1172/JCI132184. J Clin Invest. 2020. PMID: 32478682 Free PMC article.
Targeting microtubules for cancer chemotherapy.
Zhou J, Giannakakou P. Zhou J, et al. Among authors: giannakakou p. Curr Med Chem Anticancer Agents. 2005 Jan;5(1):65-71. doi: 10.2174/1568011053352569. Curr Med Chem Anticancer Agents. 2005. PMID: 15720262 Review.
Exploitation of the HIF axis for cancer therapy.
Escuin D, Simons JW, Giannakakou P. Escuin D, et al. Among authors: giannakakou p. Cancer Biol Ther. 2004 Jul;3(7):608-11. doi: 10.4161/cbt.3.7.954. Epub 2004 Jul 29. Cancer Biol Ther. 2004. PMID: 15197342 Review.
109 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page